Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 1;93(2):143-153.
doi: 10.1097/QAI.0000000000003182. Epub 2023 Mar 6.

Dynamics of Pre-Exposure (PrEP) Eligibility Because of Waxing and Waning of HIV Risk in Rakai, Uganda

Victor Ssempijja  1   2 , Robert Ssekubugu  2 , Godfrey Kigozi  2 , Gertrude Nakigozi  2 , Joseph Kagaayi  2 , Anna Mia Ekstrom  3   4 , Fred Nalugoda  2 , Betty Nantume  2 , James Batte  2 , Grace Kigozi  2 , Ping Teresa Yeh  5 , Hadijja Nakawooya  2 , David Serwadda  2   6 , Thomas C Quinn  7   8 , Ronald H Gray  2   5 , Maria J Wawer  2   5 , Kate M Grabowski  2   9 , Larry W Chang  2   5   10 , Anja Van't Hoog  11   12 , Frank Cobelens  11 , Steven J Reynolds  2   7   8
Affiliations

Dynamics of Pre-Exposure (PrEP) Eligibility Because of Waxing and Waning of HIV Risk in Rakai, Uganda

Victor Ssempijja et al. J Acquir Immune Defic Syndr. .

Abstract

Background: We conducted a retrospective population-based study to describe longitudinal patterns of prevalence, incidence, discontinuation, resumption, and durability of substantial HIV risk behaviors (SHR) for pre-exposure prophylaxis (PrEP) eligibility.

Methods: The study was conducted among HIV-negative study participants aged 15-49 years who participated in survey rounds of the Rakai Community Cohort Study between August 2011 and June 2018. Substantial HIV risk was defined based on the Uganda national PrEP eligibility as reporting sexual intercourse with >1 partner of unknown HIV status, nonmarital sex without a condom, having genital ulcers, or having transactional sex. Resumption of SHR meant resuming of SHR after stopping SHR, whereas persistence of SHR meant SHR on >1 consecutive visit. We used generalized estimation equations with log-binomial regression models and robust variance to estimate survey-specific prevalence ratios; Generalized estimation equations with modified Poisson regression models and robust variance to estimate incidence ratios for incidence, discontinuation, and resumption of PrEP eligibility.

Findings: Incidence of PrEP eligibility increased from 11.4/100 person-years (pys) in the first intersurvey period to 13.9/100 pys (adjusted incidence rate ratios = 1.28; 95%CI = 1.10-1.30) and declined to 12.6/100 pys (adjusted incidence rate ratios = 1.06; 95%CI = 0.98-1.15) in the second and third intersurvey periods, respectively. Discontinuation rates of SHR for PrEP eligibility were stable (ranging 34.9/100 pys-37.3/100 pys; P = 0.207), whereas resumption reduced from 25.0/100 pys to 14.5/100 pys ( P < 0.001). PrEP eligibility episodes lasted a median time of 20 months (IQR = 10-51).

Interpretation: Pre-exposure prophylaxis use should be tailored to the dynamic nature of PrEP eligibility. Preventive-effective adherence should be adopted for assessment of attrition in PrEP programs.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest to declare.

Figures

FIGURE 1.
FIGURE 1.
Kaplan–Meier survival curves for durability of substantial HIV risk behavior for PrEP eligibility (a: Married, b: Never married c: Previously married) in cohort B (Cohort B: Study participants with ≥2 surveys).
FIGURE 2.
FIGURE 2.
A, Transition patterns of substantial HIV risk behaviors (SHR) that qualify for PrEP eligibility. B, Stack graph for status of SHR that qualify for PrEP eligibility for the first, second, third, and fourth survey rounds.
See this image and copyright information in PMC

References

    1. Baeten JM, Donnell D, Ndase P, et al. . Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New Engl J Med. 2012;367():399–410. - PMC - PubMed
    1. Koss CA, Havlir DV, Ayieko J, et al. . HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: a population-based study in rural Kenya and Uganda. PLoS Med. 2021;18():e1003492. - PMC - PubMed
    1. Haberer JE. Current concepts for PrEP adherence: in the PrEP revolution; from clinical trials to routine practice. Curr Opin HIV AIDS 2016;11():10–17. - PMC - PubMed
    1. Haberer JE, Kidoguchi L, Heffron R, et al. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre‐exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention‐effective adherence. J Int AIDS Soc. 2017;20():21842. - PMC - PubMed
    1. World Health Organization. Updated Recommendations on First-line and Second-Line Antiretroviral Regimens and Post-Exposure Prophylaxis and Recommendations on Early Infant Diagnosis of HIV; 2018. https://www.who.int/publications/i/item/WHO-CDS-HIV-18.51.

Publication types

Substances